ITGA9: Potential Biomarkers and Therapeutic Targets in Different Tumors.

Wu, Yinxin; Chen, Jinlan; Tan, Fangshun; Wang, Bei; Xu, Wen; Yuan, Chengfu

Wu, Yinxin; Chen, Jinlan; Tan, Fangshun; Wang, Bei; Xu, Wen; Yuan, Chengfu.

Afiliación

Wu Y; Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, China.
Chen J; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
Tan F; Medical College China Three Gorges University, Yichang 443002, China.
Wang B; Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, China.
Xu W; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China.
Yuan C; Medical College China Three Gorges University, Yichang 443002, China.

Curr Pharm Des ; 28(17): 1412-1418, 2022.

Article en En | MEDLINE | ID: mdl-35490433

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Integrinas; Neoplasias Hepáticas; Neoplasias Pulmonares; Neoplasias; Biomarcadores; Humanos; Cadenas alfa de Integrinas; Integrinas/metabolismo; Neoplasias/tratamiento farmacológico

Palabras clave

ITGA9; Integrin subunits; biomarkers; cancer; mechanisms; targets

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Integrinas / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Hepáticas / Neoplasias Pulmonares / Neoplasias Límite: Humans Idioma: En Revista: Curr Pharm Des Asunto de la revista: FARMACIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google